Current treatment status-Did not start treatment yet Page 2 Posts on Medivizor
Navigation Menu

Current treatment status-Did not start treatment yet Posts on Medivizor

Comparing urinary function after robotic surgery or radical perineal surgery for early stage prostate cancer

Posted by on Mar 5, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate two less invasive surgeries in the treatment of localized prostate cancer (PCa). This study found that there was no difference in urinary symptoms 12 months after the two methods.  Some background Prostate surgery is a treatment option for prostate cancer (PCa). This surgery can be carried out by classic...

Read More

Predicting treatment success in early RA: can biomarkers predict methotrexate response?

Posted by on Feb 26, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if biomarkers (BMs) can predict the response to methotrexate (MTX) in early rheumatoid arthritis (RA). They found that the level of BMs at baseline could predict the success of MTX treatment. Some background Rheumatoid arthritis (RA) is a condition caused by inflammation. This leads to painful swelling...

Read More

Evaluating A+AVD for patients with newly diagnosed advanced Hodgkin lymphoma

Posted by on Feb 17, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of brentuximab vedotin (Adcetris) plus chemotherapy for patients with advanced (stage 3 – 4) Hodgkin’s lymphoma (HL). This study concluded that this treatment is effective for these patients. Some background The most commonly used frontline chemotherapy regimen for advanced HL...

Read More

Looking for men with newly diagnosed prostate cancer to test an immune based therapy, Sipuleucel-T

Posted by on Feb 9, 2019 in Prostate cancer | 0 comments

In a nutshell This study evaluates the effectiveness of an immunotherapy in the treatment of newly diagnosed prostate cancer. The main outcome to be measured in this trial is the number of patients whose cancer does not progress within 3 years after immunotherapy injection. This trial is taking place in many sites across the USA.  The details...

Read More

Looking for patients with advanced stage Hodgkin lymphoma to test a treatment combination

Posted by on Jan 27, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This trial is examining the effectiveness of a new treatment combination for advanced Hodgkin’s lymphoma (HL). The main outcomes to be measured will be the number of patients who experience side effects and response to treatment. This study is being conducted in New York, New Jersey, and Ohio, the United States. The details The...

Read More

Searching for patients with untreated melanoma that has spread to trial a new treatment

Posted by on Jan 19, 2019 in Melanoma | 0 comments

In a nutshell This trial aims to test the safety and effectiveness of adding a new drug called NKTR-214 to treatment with nivolumab (Opdivo) is better than just using nivolumab alone. The main outcomes that will be measured are how many people respond to treatment, how long the patients go without cancer growing or spreading, and overall...

Read More

Risk of hepatitis B reactivation in patients with lymphomas receiving obinutuzumab or rituximab

Posted by on Jan 3, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at the risk of reactivating hepatitis B (HBV) infection in patients with lymphoma treated with obinutuzumab (Gazyva) or rituximab (Rituxan). Researchers found that HBV infection was reactivated in some of these patients but treatment options are available. Some background Lymphoma is a cancer of the immune system....

Read More

Lenalidomide and dexamethasone in the treatment of chronic lymphocytic leukemia

Posted by on Dec 22, 2018 in Leukemia | 0 comments

In a nutshell The study looked at the safety and effectiveness of adding dexamethasone (Decadron) to lenalidomide (Revlimid) in previously untreated patients with chronic lymphocytic leukemia (CLL). Researchers concluded that lenalidomide plus dexamethasone is an effective treatment for CLL. Some background Chronic lymphocytic leukemia (CLL) is a...

Read More

Evaluating the use of PET scanning after first-line treatment for follicular lymphoma

Posted by on Nov 14, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the value of PET (positron emission tomography) scanning after first-line (primary) chemoimmunotherapy in patients with previously untreated follicular lymphoma (FL). This study concluded that PET scanning is a better imaging technique than CT (computed tomography) for assessing treatment response in these...

Read More